Placental Immune Failure in Males Linked to Autism Risk in New Mouse Study
A new study from Cold Spring Harbor Laboratory identifies a specific placental mechanism that may explain why autism spectrum disorder (ASD) disproportionately affects males. Researchers found that maternal immune activation during a critical 24-hour window at embryonic day 12.5 in mice causes developmental abnormalities exclusively in male fetuses. This vulnerability stems from damage to spongiotrophoblasts, specialized placental cells that maintain immune tolerance between mother and fetus. The findings suggest that male embryos may express unique proteins that trigger adverse maternal immune responses, while female fetuses possess intrinsic protective mechanisms that preserve placental integrity. This research shifts the focus from the brain to the placental interface as a primary gateway for neurodevelopmental risk.
Key points
- Maternal immune activation at embryonic day 12.5 caused developmental disruptions in approximately 30% of exposed male mouse fetuses within 24 hours.
- Female fetuses exposed to the same inflammatory environment developed normally, indicating a sex-specific vulnerability.
- Damage to spongiotrophoblasts, which form the maternal-fetal border, was linked to the loss of immune tolerance and the accumulation of cytokines like interleukin-6.
- The study suggests male embryos may express unique surface antigens that provoke maternal immune reactions, while female placentas have protective mechanisms.
- These findings challenge previous hypotheses that sex differences in autism risk are driven by late-gestation hormonal surges.
Background
Previous large-scale studies, such as the August 2026 analysis of 10 million U.S. siblings, identified birth order as a modest population-level risk marker for neurodevelopmental conditions like autism, with first-borns showing higher rates. However, those studies relied on insurance claims and did not identify biological mechanisms. The current research provides a specific biological pathway, linking maternal inflammation to placental failure in males, offering a potential target for earlier clinical intervention.
How outlets are covering it
The primary source, Newsweek, highlights the scale of the data (3.7 million births) and the rarity of the factor, though the provided text is largely technical code and lacks specific details on the 3.7 million figure. In contrast, Neuroscience News provides a detailed account of the Cold Spring Harbor Laboratory study, emphasizing the 24-hour window and the role of spongiotrophoblasts. The Telegraph source was inaccessible due to a security block, so no perspective could be extracted. The discrepancy in emphasis lies in Newsweek's focus on broad epidemiological data versus Neuroscience News's focus on specific cellular mechanisms in a mouse model.
Why it matters
Understanding the placental basis for male-specific autism vulnerability could lead to new therapeutic targets. If the protective mechanisms in female placentas can be identified and applied, it may be possible to shield vulnerable male fetuses from maternal immune activation, potentially reducing the incidence of neurodevelopmental disorders. This research moves the conversation from genetic predisposition to environmental triggers and their interaction with sex-specific biology.
What to watch
The Cheadle laboratory is currently analyzing the distinct molecular pathways active in male versus female placental cells during maternal immune activation. Future research aims to uncover how female placentas withstand maternal inflammation, which could highlight novel therapeutic targets for protecting vulnerable fetuses and enabling earlier clinical intervention.
- Scientists Tracked 3.7 Million Births—One Rare Factor Was Linked to Autism Newsweek
- Babies infected in womb ‘more likely to have autism’ The Times
- Herpes and rubella in pregnancy linked to autism The Telegraph
- Rare pregnancy infections linked to autism Medical Xpress
- The Placenta May Decide Autism Vulnerability Neuroscience News
Want the full story? Read the original reporting
Read on Newsweek